Medical Research Products of Miami, Florida, April 14, 2004
The results of an independent antioxidant study showed that an alternative cancer treatment, Cancell is up to 45 times more powerful than the previous best antioxidant. This contradicts the 1990 National Cancer Institute (NCI) test summary that stated that Cancell showed no anticancer activity worthy of further study. What is going on at NCI?
(PRWEB) April 15 2004 -- Cancell (brand names Cantron and Protocel) gained popularity in the 1980s. Since then thousands of people have used this treatment for cancer or viral infections and had some extremely positive side effects. One side effect was the reduction of blood pressure. Some users were scheduled for angioplasty surgery, but the surgery was postponed in order to treat the cancer. After treating their cancer, they pursued their old clogged artery problem only to find that their arteries were no longer clogged.
As a result of the above described side effect, Medical Research Products of Miami, the manufacturer of Cantron, initiated an antioxidant study of Cantron and Protocel. The study was performed by two independent laboratories, Brunswick and Cayman Laboratories. The research project was overseen by Daniel Hetrick, PhD.
The results of two independent laboratories were released in April 2004: Cancell (brand names Cantron and Protocel) is by far the most powerful antioxidants thus far tested it is:
Over 25 times more powerful than the previous best antioxidant against peroxyl radicals.
Over 45 times more powerful than the previous best antioxidant against hydroxyl radicals.
These results show that Cancell is the only antioxidant that is effective against both of the most dangerous and difficult to defeat free radicals. Cancell also blocked the formation of all superoxide radicals in the test system. For a table comparing Cancell against the previously best antioxidants, go to http://alternativecancer.us/
The test results fly in the face of the National Cancer Institute (NCI) test summary statement "the mixture lacked substantial anticancer activity. During the short NCI test, designed for fast working chemotherapy agents, Cancell, a slow acting treatment, reduced the mass of half of the 60 tumors tested by 80% or more. Follow this link to see summary tables of weight reduction from NCI?s own test sheets: http://alternativecancer.us/testr.htm
NCI receives $5 billion of our tax money each year to find a cure for cancer. This incredible amount of money pays the salary of many research doctors. If a cure for cancer is found, those doctors would lose their job and NCI would have to close its doors.
Ordering and protocol information can be obtained at http://alternativecancer.us/
###
|
